PDF
Beskrivning
| Land | Danmark |
|---|---|
| Lista | Spotlight DK |
| Sektor | Hälsovård |
| Industri | Läkemedel & Handel |
Minutes of Extraordinary General Meeting held in DanCann Pharma A/S, CVR-no. 39 42 60 05 ("Company")
On 21 October 2025 at 09:00 am (CET), an extraordinary general meeting was held in the Company at the Company's address, Rugvænget 5, 6823 Ansager, Denmark.
The agenda for the extraordinary general meeting was as follows:
| | Proposal to approve the board of directors' resolution of 6 October 2025 to apply for a voluntary delisting of the Company's shares from Spotlight Stock Market and adopt amendments to the Company's articles of association. (proposed by the board of directors) |
Attorney-at-law Michael Kristensen was appointed chairman of the meeting pursuant to clause 11.20 of the Company's articles of association.
The chairman of the meeting announced that the general meeting had been duly convened, as the notice of the extraordinary general meeting was given on 6 October 2025. The chairman of the meeting described the formal requirements with respect to the notice and concluded that these were met. The chairman of the meeting stated that a total of 75,000 votes were represented at the general meeting, all of which were represented by shareholders in physical attendance.
The chairman concluded that the general meeting formed a quorum with respect to the agenda.
Re 1
The board of directors of the Company has on 6 October 2025 resolved to submit an application to Spotlight Stock Market for a voluntary delisting of the Company's shares from Spotlight Stock Market pursuant to section 6.3 of the Spotlight Stock Market Regulations, subject to approval by this extraordinary general meeting by a majority of least 2/3 of the votes cast as well as 2/3 of the share capital represented at the general meeting.
Accordingly, it was proposed that the extraordinary general meeting (i) approves the board of directors' resolution to apply for a voluntary delisting of the Company's shares from Spotlight Stock Market and (ii) adopts the amendments to the Company's articles of association set out in mark-up in draft new articles of association attached as Schedule 1 (said amendments enabling the delisting of the Company's shares).
The proposed amendments to the articles of association enable the delisting of the Company's shares, and these ensure, inter alia, that the Company's shares will be freely transferable also after the delisting.
It was noted that the board of directors expects to submit an application for delisting of the Company's shares to Spotlight Stock Market on 7 January 2026.
Provided that Spotlight Stock Market approves the application for delisting, the last day of trading is expected to be on 22 January 2026.
The shares can be traded on Spotlight Stock Market in accordance with Spotlight Stock Market's Regulations up to and including the last trading day.
It was noted that a delisting of the Company's shares from trading on Spotlight Stock Market will imply that the Company's shares cannot be traded on Spotlight Stock Market, and trading in the Company's shares will take place over-the-counter ("OTC").
Tentative time plan for the delisting:
| 7 January 2026 | Application for delisting submitted to Spotlight Stock Market |
| 8 January 2026 | Spotlight Stock Market approves the delisting and announces the last day of trading of the Company's shares on Spotlight Stock Market |
| 8 January 2026 | The Company publishes a press release regarding the approval of the delisting and the last day of trading |
| 22 January 2026 | Expected last day of trading for the Company's shares on Spotlight Stock Market |
The proposal was adopted unanimously and with all votes cast.
------
The meeting was closed.
Chairman of the meeting:
__________________________
Michael Kristensen